Associated Papers
Diagnosis- and Prognosis-Related Gene Alterations in BCR::ABL1-Negative Myeloproliferative Neoplasms.
Morishita S et al.
International Journal of Molecular Sciences, 2023
37629188 (PubMed )
Supplement: ijms-24-13008-s001.zip › ijms-2555672-supplementary.pdf
Insights from a rare myeloproliferative neoplasm with coexisting BCR-ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib.
Huo L et al.
Clinical Case Reports, 2023
Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.
Tvorogov D et al.
Embo Reports, 2022
35156745 (PubMed )
Supplement: EMBR-23-e52904-s006.pdf
Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice.
Minakawa K et al.
Journal of Hematology & Oncology, 2021
33785036 (PubMed )
Supplement: 13045_2021_1064_MOESM7_ESM.pdf
Calreticulin Mutations in Bulgarian MPN Patients.
Pavlov I et al.
Pathology Oncology Research : Por, 2018
A novel molecular assay using hybridisation probes and melt curve analysis for CALR exon 9 mutation detection in myeloproliferative neoplasms.
Keaney T et al.
Journal of Clinical Pathology, 2017
Isolated erythrocytosis associated with a CALR mutation.
Langabeer SE et al.
Blood Cells, Molecules & Diseases, 2017
BAMClipper: removing primers from alignments to minimize false-negative mutations in amplicon next-generation sequencing.
Au CH et al.
Scientific Reports, 2017
28484262 (PubMed )
Supplement: 41598_2017_1703_MOESM1_ESM.pdf
Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.
Kang MG et al.
Oncotarget, 2016
Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH et al.
Diagnostic Pathology, 2016
Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring.
Chi J et al.
Annals of Hematology, 2015
Incidence, clinical features, and prognostic impact of CALR exon 9 mutations in essential thrombocythemia and primary myelofibrosis: an experience of a single tertiary hospital in Korea.
Park SH et al.
Annals of Laboratory Medicine, 2015
Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.
Andrikovics H et al.
Haematologica, 2014
Select a paper to view details